Goto Y, Shukuya T, Murata A, Kikkawa H, et al. Real-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancer. Cancer Sci 2023;114:2560-2568.
PMID: 36866958